Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML
Clinical trial NCT05334693 · RECRUITING
Trial details
- NCT number
- NCT05334693
- Sponsor
- Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2025-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.